Background: Multiple system atrophy (MSA) patients pre-sent a variety of symptoms other than autonomic dysfunctions, parkinsonism, and cerebellar ataxia. The aim of this study was to evaluate the frequency of various motor and non-motor symptoms including so-called “red flags” in patients with early MSA and to determine whether the frequency of these symptoms was different between the parkinsonian (MSA-P) and cerebellar (MSA-C) subtypes. Methods: Sixty-one probable or possible MSA patients with disease duration of 3 years or less were included. Patients were classified into MSA-P, MSA-C, and MSA-PC. The frequency of 13 features including various motor and non-motor symptoms that commonly occur in MSA was assessed. Results: Dysarthria was the most prevalent feature (98.4%) followed by sexual dysfunction (95.1%). Probable REM sleep behavior disorder was present in 90.2%. The frequency of constipation (82.0%), dysphagia (68.9%), and snoring (70.5%) was also high. Stridor was present in 42.6% and more common in MSA-C than in MSA-P. Conclusions: Increasing awareness of various motor and non-motor symptoms may assist clinicians to make an early, accurate diagnosis and to improve management of patients with MSA. We suggest that the diagnostic accuracy can be improved if these features are appropriately reflected in the new diagnostic criteria for MSA.

1.
Quinn
N
.
Multiple system atrophy—the nature of the beast
.
J Neurol Neurosurg Psychiatry
.
1989
Jun
;
52
Suppl
:
78
89
.
[PubMed]
0022-3050
2.
Gilman
S
,
Wenning
GK
,
Low
PA
,
Brooks
DJ
,
Mathias
CJ
,
Trojanowski
JQ
, et al.
Second consensus statement on the diagnosis of multiple system atrophy
.
Neurology
.
2008
Aug
;
71
(
9
):
670
6
.
[PubMed]
0028-3878
3.
Köllensperger
M
,
Geser
F
,
Seppi
K
,
Stampfer-Kountchev
M
,
Sawires
M
,
Scherfler
C
, et al.;
European MSA Study Group
.
Red flags for multiple system atrophy
.
Mov Disord
.
2008
Jun
;
23
(
8
):
1093
9
.
[PubMed]
0885-3185
4.
Ogaki
K
,
Fujioka
S
,
Heckman
MG
,
Rayaprolu
S
,
Soto-Ortolaza
AI
,
Labbé
C
, et al.
Analysis of COQ2 gene in multiple system atrophy
.
Mol Neurodegener
.
2014
Nov
;
9
(
1
):
44
.
[PubMed]
1750-1326
5.
Labbé
C
,
Heckman
MG
,
Lorenzo-Betancor
O
,
Murray
ME
,
Ogaki
K
,
Soto-Ortolaza
AI
, et al.
MAPT haplotype diversity in multiple system atrophy
.
Parkinsonism Relat Disord
.
2016
Sep
;
30
:
40
5
.
[PubMed]
1353-8020
6.
Lee
HH
,
Seo
HG
,
Kim
KD
,
Lee
SH
,
Lee
WH
,
Oh
BM
, et al.
Characteristics of Early Oropharyngeal Dysphagia in Patients with Multiple System Atrophy
.
Neurodegener Dis
.
2018
;
18
(
2-3
):
84
90
.
[PubMed]
1660-2854
7.
Hoehn
MM
,
Yahr
MD
.
Parkinsonism: onset, progression and mortality
.
Neurology
.
1967
May
;
17
(
5
):
427
42
.
[PubMed]
0028-3878
8.
Wenning
GK
,
Tison
F
,
Seppi
K
,
Sampaio
C
,
Diem
A
,
Yekhlef
F
, et al.;
Multiple System Atrophy Study Group
.
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
.
Mov Disord
.
2004
Dec
;
19
(
12
):
1391
402
.
[PubMed]
0885-3185
9.
Postuma
RB
,
Arnulf
I
,
Hogl
B
,
Iranzo
A
,
Miyamoto
T
,
Dauvilliers
Y
, et al.
A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study
.
Mov Disord
.
2012
Jun
;
27
(
7
):
913
6
.
[PubMed]
0885-3185
10.
Gilman
S
,
Low
PA
,
Quinn
N
,
Albanese
A
,
Ben-Shlomo
Y
,
Fowler
CJ
, et al.
Consensus statement on the diagnosis of multiple system atrophy
.
J Neurol Sci
.
1999
Feb
;
163
(
1
):
94
8
.
[PubMed]
0022-510X
11.
Osaki
Y
,
Wenning
GK
,
Daniel
SE
,
Hughes
A
,
Lees
AJ
,
Mathias
CJ
, et al.
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?
Neurology
.
2002
Nov
;
59
(
10
):
1486
91
.
[PubMed]
0028-3878
12.
Osaki
Y
,
Ben-Shlomo
Y
,
Lees
AJ
,
Wenning
GK
,
Quinn
NP
.
A validation exercise on the new consensus criteria for multiple system atrophy
.
Mov Disord
.
2009
Nov
;
24
(
15
):
2272
6
.
[PubMed]
0885-3185
13.
Müller
J
,
Wenning
GK
,
Verny
M
,
McKee
A
,
Chaudhuri
KR
,
Jellinger
K
, et al.
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders
.
Arch Neurol
.
2001
Feb
;
58
(
2
):
259
64
.
[PubMed]
0003-9942
14.
Papatsoris
AG
,
Papapetropoulos
S
,
Singer
C
,
Deliveliotis
C
.
Urinary and erectile dysfunction in multiple system atrophy (MSA)
.
Neurourol Urodyn
.
2008
;
27
(
1
):
22
7
.
[PubMed]
0733-2467
15.
Kirchhof
K
,
Apostolidis
AN
,
Mathias
CJ
,
Fowler
CJ
.
Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study
.
Int J Impot Res
.
2003
Aug
;
15
(
4
):
293
8
.
[PubMed]
0955-9930
16.
Oertel
WH
,
Wächter
T
,
Quinn
NP
,
Ulm
G
,
Brandstädter
D
.
Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type
.
Mov Disord
.
2003
Apr
;
18
(
4
):
430
2
.
[PubMed]
0885-3185
17.
St Louis
EK
,
Boeve
AR
,
Boeve
BF
.
REM Sleep Behavior Disorder in Parkinson’s Disease and Other Synucleinopathies
.
Mov Disord
.
2017
May
;
32
(
5
):
645
58
.
[PubMed]
0885-3185
18.
Duarte Folle
A
,
Paul
KC
,
Bronstein
JM
,
Keener
AM
,
Ritz
B
.
Clinical progression in Parkinson’s disease with features of REM sleep behavior disorder: A population-based longitudinal study
.
Parkinsonism Relat Disord
.
2019
May
;
62
:
105
11
.
[PubMed]
1353-8020
19.
Zhang
X
,
Sun
X
,
Wang
J
,
Tang
L
,
Xie
A
. Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease: a meta and meta-regression analysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.
2017
Jan;38(1):163-70.
20.
Munhoz
RP
,
Teive
HA
.
REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism?
Clin Neurol Neurosurg
.
2014
Dec
;
127
:
71
4
.
[PubMed]
0303-8467
21.
Friedman
JH
,
Fernandez
HH
,
Sudarsky
LR
.
REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3)
.
Mov Disord
.
2003
Dec
;
18
(
12
):
1520
2
.
[PubMed]
0885-3185
22.
Kim
HJ
,
Jeon
BS
,
Shin
J
,
Lee
WW
,
Park
H
,
Jung
YJ
, et al.
Should genetic testing for SCAs be included in the diagnostic workup for MSA?
Neurology
.
2014
Nov
;
83
(
19
):
1733
8
.
[PubMed]
0028-3878
23.
Zhang
L
,
Cao
B
,
Ou
R
,
Wei
QQ
,
Zhao
B
,
Yang
J
, et al.
Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes
.
Parkinsonism Relat Disord
.
2017
Feb
;
35
:
63
8
.
[PubMed]
1353-8020
24.
Do
HJ
,
Seo
HG
,
Lee
HH
,
Oh
BM
,
Kim
Y
,
Kim
A
, et al.
Progression of Oropharyngeal Dysphagia in Patients with Multiple System Atrophy
.
Dysphagia
.
2019
Mar
.
[PubMed]
0179-051X
25.
Guo
XY
,
Cao
B
,
Lei
F
,
Huang
L
,
Chen
K
,
Song
W
, et al.
Clinical and polysomnographic features of patients with multiple system atrophy in Southwest China.
Sleep & breathing = Schlaf & Atmung.
2013
Dec;17(4):1301-7.
26.
Rekik
S
,
Martin
F
,
Dodet
P
,
Redolfi
S
,
Leu-Semenescu
S
,
Corvol
JC
, et al.
Stridor combined with other sleep breathing disorders in multiple system atrophy: a tailored treatment?
Sleep Med
.
2018
Feb
;
42
:
53
60
.
[PubMed]
1389-9457
27.
Cochen De Cock
V
,
Abouda
M
,
Leu
S
,
Oudiette
D
,
Roze
E
,
Vidailhet
M
, et al.
Is obstructive sleep apnea a problem in Parkinson’s disease?
Sleep Med
.
2010
Mar
;
11
(
3
):
247
52
.
[PubMed]
1389-9457
28.
Jecmenica-Lukic
M
,
Poewe
W
,
Tolosa
E
,
Wenning
GK
.
Premotor signs and symptoms of multiple system atrophy
.
Lancet Neurol
.
2012
Apr
;
11
(
4
):
361
8
.
[PubMed]
1474-4422
29.
Ozawa
T
,
Sekiya
K
,
Aizawa
N
,
Terajima
K
,
Nishizawa
M
.
Laryngeal stridor in multiple system atrophy: clinicopathological features and causal hypotheses
.
J Neurol Sci
.
2016
Feb
;
361
:
243
9
.
[PubMed]
0022-510X
30.
Gan
EC
,
Lau
DP
,
Cheah
KL
.
Stridor in Parkinson’s disease: a case of ‘dry drowning’?
J Laryngol Otol
.
2010
Jun
;
124
(
6
):
668
73
.
[PubMed]
0022-2151
31.
Cortelli
P
,
Calandra-Buonaura
G
,
Benarroch
EE
,
Giannini
G
,
Iranzo
A
,
Low
PA
, et al.
Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment
.
Neurology
.
2019
Oct
;
93
(
14
):
630
9
.
[PubMed]
0028-3878
32.
Giannini
G
,
Calandra-Buonaura
G
,
Mastrolilli
F
,
Righini
M
,
Bacchi-Reggiani
ML
,
Cecere
A
, et al.
Early stridor onset and stridor treatment predict survival in 136 patients with MSA
.
Neurology
.
2016
Sep
;
87
(
13
):
1375
83
.
[PubMed]
0028-3878
33.
Zhang
L
,
Cao
B
,
Zou
Y
,
Wei
QQ
,
Ou
R
,
Zhao
B
, et al.
Prevalence of and factors associated with postural deformities in Chinese patients with multiple system atrophy
.
Parkinsonism Relat Disord
.
2019
Jul
;
64
:
324
7
.
[PubMed]
1353-8020
34.
Minnerop
M
,
Specht
K
,
Ruhlmann
J
,
Schimke
N
,
Abele
M
,
Weyer
A
, et al.
Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters
.
Neuroimage
.
2007
Jul
;
36
(
4
):
1086
95
.
[PubMed]
1053-8119
35.
Kim
HW
,
Oh
M
,
Oh
JS
,
Oh
SJ
,
Lee
SJ
,
Chung
SJ
, et al.
Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET
.
PLoS One
.
2017
Jan
;
12
(
1
):
e0169928
.
[PubMed]
1932-6203
36.
Ahmed
A
,
Simmons
Z
.
Pseudobulbar affect: prevalence and management
.
Ther Clin Risk Manag
.
2013
;
9
:
483
9
.
[PubMed]
1176-6336
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.